Directed sibling donor cord blood banking for children with beta-thalassemia major in Greece: usage rate and outcome of transplantation for HLA-matched units
- PMID: 19931473
- DOI: 10.1016/j.bcmd.2009.10.011
Directed sibling donor cord blood banking for children with beta-thalassemia major in Greece: usage rate and outcome of transplantation for HLA-matched units
Abstract
Several cord blood banks store cord blood units from healthy siblings of patients, who are candidates for stem cell transplantation. We analyzed the quality characteristics of 50 cord blood units collected from families with beta-thalassemia major and the outcome of subsequent stem cell transplantations during a 15-year period. All cord blood units were found suitable for banking based on a minimum net volume of 40 ml. The mean volume of the units was 98.9 ml; the mean total nucleated cell count (NC) was 7.8 x 10(8) and the mean CD34+ cell count was 2.8 x 10(6). Eight out of twelve HLA matched collections were released for transplantation. All but one recipient belonged to Pesaro II-III risk classes. Three patients received a cord blood graft with >5 x 10(7) NC/kg . One of them with Pesaro class I disease engrafted, whereas the other two who failed to engraft, were re-transplanted with bone marrow from the same donor later. Cord blood grafts containing NCs <4 x 10(7)/kg combined with reduced volume bone marrow from the same donor were used in all 5 remaining cases and stable engraftment was achieved. All patients survived, 7/8 thalassemia-free. Cord blood banking from healthy siblings of children with beta-thalassemia major can result in a successful transplantation in cases in which there is HLA compatibility. However, in high-risk patients, the use of combined cord blood and bone marrow grafts seems necessary in order to ensure stable engraftment, especially when cord blood unit cell counts are low.
Copyright (c) 2009 Elsevier Inc. All rights reserved.
Similar articles
-
Low usage rate of banked sibling cord blood units in hematopoietic stem cell transplantation for children with hematological malignancies: implications for directed cord blood banking policies.Blood Cells Mol Dis. 2011 Feb 15;46(2):177-81. doi: 10.1016/j.bcmd.2010.10.017. Epub 2010 Nov 20. Blood Cells Mol Dis. 2011. PMID: 21095146
-
Donor/recipient mixed chimerism does not predict graft failure in children with beta-thalassemia given an allogeneic cord blood transplant from an HLA-identical sibling.Haematologica. 2008 Dec;93(12):1859-67. doi: 10.3324/haematol.13248. Epub 2008 Oct 22. Haematologica. 2008. PMID: 18945748
-
Haematopoietic transplant potential of unrelated and related cord blood: the first six years of the EUROCORD/NETCORD Bank Germany.Klin Padiatr. 1999 Jul-Aug;211(4):224-32. doi: 10.1055/s-2008-1043793. Klin Padiatr. 1999. PMID: 10472555 Clinical Trial.
-
[Umbilical cord blood as a source of stem cells].Acta Med Croatica. 2006 Jun;60(3):215-25. Acta Med Croatica. 2006. PMID: 16933834 Review. Croatian.
-
Cord blood stem cell transplantation for haemoglobinopathies.Br J Haematol. 2008 May;141(3):309-24. doi: 10.1111/j.1365-2141.2008.07016.x. Epub 2008 Feb 26. Br J Haematol. 2008. PMID: 18307566 Review.
Cited by
-
The Role of HLA in Cord Blood Transplantation.Bone Marrow Res. 2012;2012:485160. doi: 10.1155/2012/485160. Epub 2012 Oct 11. Bone Marrow Res. 2012. PMID: 23097706 Free PMC article.
-
Family-directed umbilical cord blood banking.Haematologica. 2011 Nov;96(11):1700-7. doi: 10.3324/haematol.2011.047050. Epub 2011 Jul 12. Haematologica. 2011. PMID: 21750089 Free PMC article. Review.
-
Alternative Donor/Unrelated Donor Transplants for the β-Thalassemia and Sickle Cell Disease.Adv Exp Med Biol. 2017;1013:123-153. doi: 10.1007/978-1-4939-7299-9_5. Adv Exp Med Biol. 2017. PMID: 29127679 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials